Erika Elgstrand Wettergren - Publications

Affiliations: 
Wallenberg Neuroscience Center, Lund University, Lund, Skåne län, Sweden 

6 high-probability publications. We are testing a new system for linking publications to authors. You can help! If you notice any inaccuracies, please sign in and mark papers as correct or incorrect matches. If you identify any major omissions or other inaccuracies in the publication list, please let us know.

Year Citation  Score
2016 Breger L, Wettergren EE, Quintino L, Lundberg C. Regulated Gene Therapy. Methods in Molecular Biology (Clifton, N.J.). 1382: 57-66. PMID 26611578 DOI: 10.1007/978-1-4939-3271-9_4  0.673
2014 Wettergren EE, Quintino L, Lundberg C. Gene therapy using synthetic microRNA directed against GAD67 has beneficial effect on motor behaviour in 6-OHDA lesioned rats Journal of Gene Therapy Aspects. 1: 1. DOI: 10.7243/2057-164X-1-1  0.676
2014 Wettergren EE, Quintino L, Manfré G, Lundberg C. Gene therapy for Parkinson’s disease Neuromethods. 82: 181-191. DOI: 10.1007/978-1-62703-610-8_10  0.731
2013 Quintino L, Manfré G, Wettergren EE, Namislo A, Isaksson C, Lundberg C. Functional neuroprotection and efficient regulation of GDNF using destabilizing domains in a rodent model of Parkinson's disease. Molecular Therapy : the Journal of the American Society of Gene Therapy. 21: 2169-80. PMID 23881415 DOI: 10.1038/Mt.2013.169  0.72
2013 Ã…kerblom M, Sachdeva R, Quintino L, Wettergren EE, Chapman KZ, Manfre G, Lindvall O, Lundberg C, Jakobsson J. Visualization and genetic modification of resident brain microglia using lentiviral vectors regulated by microRNA-9. Nature Communications. 4: 1770. PMID 23612311 DOI: 10.1038/Ncomms2801  0.667
2012 Wettergren EE, Gussing F, Quintino L, Lundberg C. Novel disease-specific promoters for use in gene therapy for Parkinson's disease. Neuroscience Letters. 530: 29-34. PMID 23063686 DOI: 10.1016/J.Neulet.2012.09.059  0.594
Show low-probability matches.